section name header

Pronunciation ⬇

nee-oh-MYE-sin audio

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption, but may accumulate in patients with renal failure.

Distribution: Widely distributed throughout extracellular fluid; crosses the placenta; small amounts enter breast milk. Poor penetration into CSF.

Metabolism/Excretion: Excretion is >90% renal.

Half-life: 2–4 hr (increased in renal impairment).

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

GI: diarrhea, nausea, vomiting.

Misc: hypersensitivity reactions.

Interactions ⬆ ⬇

Interactions are listed for systemically absorbed drug

Drug-Drug:

Route/Dosage ⬆ ⬇

see Calculator

Preoperative Intestinal Antisepsis

Hepatic Encephalopathy

Implementation ⬆ ⬇

Classifications ⬆ ⬇

Therapeutic Classification: anti-infectives

Pharmacologic Classification: aminoglycosides

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

(blood levels)

ROUTEONSETPEAKDURATION
POrapid1–4 hrN/A

Assessment ⬆ ⬇

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code*